India Juris advises Protech Biosystems on acquisition of Alchemy Medicine

01 August 2013

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.
India Juris assisted the promoters of Protech from start to end in the acquisition of Roorkee, India based pharma company Alchemy Medicine Pvt Ltd. The transaction was complex which involved conversion of partnership into company and then acquisition. The scope of work included due diligence, corporate and foreign exchange law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.
The transaction was successfully completed to the satisfaction of the client.

News & Deals

IJ advised on Beyond Renewables’ pre-seed funding round

IJ advised Investor in Reia pre-seed funding

IJ advised the Investor in VAMA’s INR 22 Crore Pre-Series A funding round.

Publications

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

AML Issues & Compliances By Entities In GIFT City

Newsletters

Recent Competition Law Updates

REGULATING THE FUTURE: INDIA’S HESITANT PATH VS. THE UK’S PRAGMATIC BLUEPRINT FOR CRYPTO MARKETS

Indian Banks and Russian Oil: How Sanctions are Reshaping India’s Energy Trade